A qualitative study on people with opioid use disorders' perspectives on smoking and smoking cessation interventions

Karl Trygve Druckrey-Fiskaaen; Einar Furulund; Tesfaye Madebo; Siv-Elin Leirvåg Carlsen; Lars T Fadnes; Torgeir Gilje Lid; for ATLAS4LAR Study Group

doi:10.3389/fpsyt.2023.1185338

A qualitative study on people with opioid use disorders' perspectives on smoking and smoking cessation interventions

Front Psychiatry. 2023 Aug 10:14:1185338. doi: 10.3389/fpsyt.2023.1185338. eCollection 2023.

Authors

Karl Trygve Druckrey-Fiskaaen^{1

2}, Einar Furulund^{1

2

3}, Tesfaye Madebo^{1

4}, Siv-Elin Leirvåg Carlsen¹, Lars T Fadnes^{1

2}, Torgeir Gilje Lid^{1

3}; for ATLAS4LAR Study Group

Affiliations

¹ Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.
² Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
³ Centre for Alcohol and Drug Research, Stavanger University Hospital, Stavanger, Norway.
⁴ Department of Respiratory Medicine, Stavanger University Hospital, Stavanger, Norway.

Abstract

Introduction: Smoking-related diseases are major contributors to disability and shorter life expectancy among opioid-dependent patients. Smoking prevalence is considerably higher for opioid-dependent persons than among the general population, and only a minority quit smoking in treatment settings. Studies show that pharmacological smoking cessation interventions have modest success rates. This study aimed to investigate patients' receiving opioid agonist therapy perspectives on factors affecting behavior and decisions related to smoking cessation, and their experiences with smoking cessation.

Methods: This is a qualitative study using semi-structured individual interviews. The participants were asked, among others, to elaborate on the participants' thoughts about smoking, previous attempts to quit tobacco use, and what could prompt a smoking cessation attempt. We analyzed the transcripts with systematic text condensation. The Standards for Reporting Qualitative Research and the Consolidated Criteria for Reporting Qualitative Research guidelines were followed. Opioid-dependent patients receiving opioid agonist therapy in outpatient clinics were invited to participate using a purposive sampling method. In total, fourteen individuals participated in this study.

Results: We identified six themes which were: (1) reflections on how smoking affected decisions, (2) smoking and its impact on physical and mental health, (3) the economy as a motivator to stop smoking, (4) emotions, desires, and habits related to smoking, (5) knowledge of smoking, smoking cessation, and quit attempts, and (6) social factors influencing the participants' choices and activities. The participants were well informed about the consequences of smoking and had some knowledge and experience in quitting. The participants' pulmonary health was an important motivational factor for change. Withdrawal symptoms, anxiety, and fear of using other substances discouraged several from attempting to quit smoking. In contrast, social support from partners and access to meaningful activities were considered important factors for success. Few reported being offered help from health professionals to make a smoking cessation attempt.

Discussion: Experiencing social support, being encouraged to quit smoking, and patients' concerns for their physical health were important reasons for wanting to quit smoking. Smoking cessation interventions based on patient preferences and on the behavior change wheel may enable a higher success rate among patients receiving opioid agonist therapy.

Keywords: COM-B; opioid agonist treatment; qualitative study; smoking cessation; systematic text condensation; tobacco.